SDY vs VHT
SPDR S&P Dividend ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.35% for SDY.
- • SDY pays a higher dividend yield (2.35%).
Side-by-side metrics
| Metric | SDY | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.09% |
Dividend yield Trailing 12-month yield. | 2.35% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $23.87B | $23.73B |
YTD return | 19.71% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.48 | 0.46 |
P/E ratio | 18.98 | 32.41 |
Last price | $163.50 | $347.68 |
Inception | — | — |
Issuer | State Street | Vanguard |
SDY top holdings
| ACN | Accenture PLC Class A | 4.02% |
| VZ | Verizon Communications Inc | 2.81% |
| CVX | Chevron Corp | 2.18% |
| O | Realty Income Corp | 1.91% |
| PEP | PepsiCo Inc | 1.84% |
| MDT | Medtronic PLC | 1.81% |
| TGT | Target Corp | 1.63% |
| ADP | Automatic Data Processing Inc | 1.53% |
| NKE | Nike Inc Class B | 1.52% |
| XOM | ExxonMobil Holdings Corp | 1.52% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About SDY
SDY (SPDR S&P Dividend ETF) is Highest-yielding S&P Composite 1500 dividend growers. Managed by State Street, the fund carries $23.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 2.35%. Its largest holding is Accenture PLC Class A (ACN), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 3.7%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.